1. Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome
   Dan Li et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
2. The Functions of Cytochrome P450 ω-hydroxylases and the Associated Eicosanoids in Inflammation-Related Diseases
   Kai-Di Ni et al, 2021, Frontiers in Pharmacology CrossRef
3. Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells
   Laura Contreras et al, 2022, Cancers CrossRef
4. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development
   Mario M. Alba et al, 2023, Frontiers in Physiology CrossRef
5. Human Orphan Cytochromes P450: An Update
   Dora Molina-Ortiz et al, 2022, Current Drug Metabolism CrossRef
6. Overexpression of NNT-AS1 Activates TGF-β Signaling to Decrease Tumor CD4 Lymphocyte Infiltration in Hepatocellular Carcinoma
   Yakun Wang et al, 2020, BioMed Research International CrossRef
7. Genetic polymorphisms in CYP4F2 may be associated with lung cancer risk among females and no-smoking Chinese population
   Hongyang Shi et al, 2023, Frontiers in Oncology CrossRef